Tasimelteon Capsule, Gelatin Coated
Product Images NDC 0480-4490

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Tasimelteon (NDC 0480-4490). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (Image 1)

FDA Label Image

Label 20 mg, 30 Capsules (Image 2)

Label 20 mg, 30 Capsules (Image 2)
This is a description of a medication called tasimelteon, which comes in capsule form with each capsule containing 20mg of the medication. The usual dosage is 20mg per day, taken before bed. The medication should be kept at controlled room temperature, protected from light and moisture. It is important to keep all medications, including this one, out of reach of children. The medication is manufactured in India by Watson Pharma Private Limited and is distributed by Teva Pharmaceuticals in Parsippany, NJ.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.